Biocatalysis and Molecular Medcine

ESAB and SKB are pleased to invite you to the Webinar on the new topic Biocatalysis and Molecular Medicine, bridging the communities of biocatalysis/industrial biotechnology and molecular medicine.

10:00 – 10:30 CEST	Critical mechanisms in the pathogenesis of persistent bacterial infections Prof. Dr. Thomas F. Meyer Max Planck Institute for Infection Biology, Department of Molecular Biology, Berlin, and Laboratory of Infection Oncology, Institute of Clinical Molecular Biology, Christian Albrecht’s University of Kiel and University Hospital Schleswig Holstein – Campus Kiel, Germany
10:30 – 11:00 CEST	Mucopolysaccharidoses – molecular mechanisms and treatment options of disorders caused by defects in biocatalysis of glycosaminoglycan decay  Prof. Dr. Grzegorz Wegrzyn Department of Molecular Biology, Faculty of Biology, University of Gdansk, Wita Stwosza 59, 80-308 Gdansk, Poland
11:00 – 11:30 CEST	Biocatalysis in Cells through Proteolysis Targeting Chimeras (PROTACs): How to Improve Cell Permeability and Achieve Successful Protein Degradation Prof. Dr. Leonardo Scapozza School of Pharmaceutical Sciences, and Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Switzerland
11:30 – 12:00 CEST	The use of systems biology in treatment of liver diseases Prof. Dr. Adil Mardinoglu Science for Life Laboratory, KTH – Royal Institute of Technology, Stockholm, Sweden, and Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King’s College London, London, United Kingdom